Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kintor Pharmaceutical Ltd (OP: KNTPF )

0.1400 +0.0184 (+15.13%)
Streaming Delayed Price Updated: 2:24 PM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,500
Open 0.1400
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1216
Today's Range 0.1400 - 0.1400
52wk Range 0.1000 - 0.6123
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Week In Review: Two China Biopharmas Announce Billion Dollar Deals
MediLink Therapeutics out-licensed global rights for its antibody-drug conjugate candidate to BioNTech in a $1.1 billion agreement. Meanwhile, BioMap formed a collaboration with Sanofi in a deal with... 
Via Talk Markets
Week In Review: CANbridge In-Licenses Gene Therapy For Rare Disease From UMass
CANbridge Pharma exercised an option for global rights to a novel second-gen gene therapy from UMass Chan medical school. Additionally, Zhimeng Biopharma signed an agreement to out-license global... 
Via Talk Markets

Performance

YTD
+40.00%
+40.00%
1 Month
-17.65%
-17.65%
3 Month
+40.00%
+40.00%
6 Month
-63.87%
-63.87%
1 Year
-77.14%
-77.14%

More News

Read More
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.